Ureteral Stents Market Size & Share, by Product Type (Double Pigtail Stents, Multi-length Stents, Open-End Stents, Closed-End Stents); Application; End user; Material; Coating; Length - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

Ureteral Stents Market - Regional Analysis

North America Market Insights

North America is expected to dominate the worldwide ureteral stents market, capturing the largest share of 35.7% by the end of 2035. The region's dominance in this field is attributed to the advancements in medical technology and rising healthcare investments.  As evidence, the 2024 UDA report revealed that the Medicare FFS expenditures for key urologic conditions in patients aged above 65 totaled USD 2.8 billion in 2021.  Besides, the urinary stone disease resulted in $1.1 billion, and benign prostatic hyperplasia $1.3 billion, hence further boosting the adoption of ureteral stents across the region.

The U.S. is reinforcing its leadership in the regional market owing to the increasing patient awareness and enhanced access to advanced healthcare facilities. In this regard Journal of Comparative Effectiveness Research in October 2022 analyzed the data from over 16,000 patients in the country, which found that encrusted stents, delayed removal, and certain demographic factors contributed to procedural complexity and cost escalation. Therefore, the study underscores the need for innovations like anti-encrustation stents or biodegradable stents, thereby encouraging more players to establish their footprint in this field.

There is a huge opportunity for the ureteral stents market in Canada since there is a constant rise in the cases of urinary tract disorders, increasing awareness of minimally invasive processes, and supportive regulatory frameworks. In February 2024, Health Canada reported that it had approved an amendment to the Class III medical device license for the Urosoft Ureteral Stent Set manufactured by Angiomed GmbH & Co. Besides, the stent is designed for the treatment of ureteral obstructions or strictures and for postoperative drainage, hence denoting a positive market outlook.

Medicare Reimbursement for Ureteral Stent Procedures 2021 (USD)

Source: NIH

APAC Market Insights

Asia Pacific is considered to be the fastest-growing region in the market from 2026 to 2035. The region’s upliftment in this field is effectively catered to the increasing urological procedure volumes, expanding healthcare infrastructure, and greater awareness around kidney stone disease and ureteral obstructions. Besides, there has been a strong penetration of health insurance and government support for minimally invasive procedures, due to which countries across the region are increasingly adopting advanced stenting technologies.

China is also continuously growing in the Asia Pacific’s ureteral stents market, facilitated by its large population base and the government’s investment in expanding tertiary care hospitals. The study by NIH in December 2023 observed that over the last decade, private hospitals increased by 193.4% in the country, which is reshaping access to urological care. Besides, the increase in outpatient visits and surgical procedures has boosted demand for devices like ureteral stents, further boosting device adoption across the private healthcare landscape.

India is demonstrating notable growth in the ureteral stents market, supported by the improvements in public and private healthcare infrastructure, as well as the growing availability of urological specialists. In April 2025, the country’s Health Minister, Shri Jagat Prakash Nadda, inaugurated the new Centre for Nephrology and Urology at Symbiosis University Hospital & Research Centre in Pune, which is equipped with state-of-the-art dialysis, transplantation, and kidney stone management services, thereby providing opportunities for device suppliers to meet evolving clinical needs.

Europe Market Insights

Europe is gaining traction in the market, effectively driven by the implementation of mutually beneficial collaborations, technological advancements, and strong healthcare infrastructure. In February 2025, Micro-Tech finalized the acquisition of a 51% stake in Creo Medical S.L.U. (CME), which is a key European distributor specializing in urology, gastroenterology, and single-use endoscopic devices. This move enhances Micro-Tech’s access to nearly 5,000 healthcare institutions across Western Europe and is expected to support wider distribution of its endoscopic and urological products, including ureteral stents, hence an optimistic market opportunity.

Germany is the key player in Europe’s ureteral stents market, which is extensively supported by the strong healthcare infrastructure and a high volume of urological procedures. The country is also home to key industry players, wherein the pioneer Medi-Globe Group in April 2022 reported that its flagship product, called Magnetic Black-Star, has been proven superior to conventional stents in a systematic review of worldwide studies. The review, published in the Irish Journal of Medical Science, concluded that the Magnetic Black-Star results in less pain during stent removal and leads to cost savings compared to traditional ureteral stents.

U.K. market is poised for exceptional growth, which is characterized by high adoption rates of advanced medical technologies and stringent regulatory standards guided by the National Institute for Health and Care Excellence (NICE). In July 2022, the University of Southampton, with a key emphasis on improving care for patients with urinary stents,  launched a £1.3 million clinical trial funded by the National Institute for Health and Care Research (NIHR). Besides, the project aims to test a newly designed ureteral stent that could significantly reduce the common issues of stent failure and discomfort experienced by patients.

Historic Urology Health Statistics in the UK (2017-2019)

Source: Urology Foundation